CCP
PFE icon

Clifford Capital Partners’s Pfizer PFE Stock Holding History

Clifford Capital Partners’s Portfolio PFE Stock Details PFE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-715,864
Closed -$18.1M – 50
2025
Q1 		$18.1M Buy
715,864
+147,814
+26% +$3.87M 3.73% 7
2024
Q4 		$15.1M Sell
568,050
-20,398
-3% -$553K 3.12% 14
2024
Q3 		$17M Buy
588,448
+51,703
+10% +$1.51M 3.39% 11
2024
Q2 		$15M Buy
536,745
+94,152
+21% +$2.59M 3.27% 13
2024
Q1 		$12.3M Buy
442,593
+100,210
+29% +$2.78M 3.12% 18
2023
Q4 		$9.86M Buy
+342,383
New +$10.4M 2.54% 25

Other funds holding PFE

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
State Farm Mutual Automobile Insurance
State Farm Mutual Automobile Insurance Bloomington, Illinois $146B AUM 55.73% 1-Year Est. Return

Clifford Capital Partners's PFE Position: Q2 2025 in Review

Clifford Capital Partners sold out of Pfizer (PFE) in Q2 2025, closing a stake of 715,864 shares — an estimated $18.1M sold.

Clifford Capital Partners first reported a position in PFE in Q4 2023 and held it in 6 quarters. The position peaked at $18.1M in Q1 2025. 2,813 funds tracked by Wall St. Rank hold PFE as of Q2 2025.

  • Clifford Capital Partners reported no remaining Pfizer position as of Q2 2025 after selling out during the quarter.
  • Clifford Capital Partners sold 715,864 Pfizer shares in Q2 2025, an estimated $18.1M.
  • Clifford Capital Partners first reported a position in Pfizer in Q4 2023 and held it in 6 quarters.
  • Clifford Capital Partners's Pfizer position peaked at $18.1M in Q1 2025.
  • 2,813 funds tracked by Wall St. Rank held Pfizer as of Q2 2025.

Based on Clifford Capital Partners's 13F filing for Q2 2025, filed 12 Aug 2025.